Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Brain pathology (Zurich, Switzerland)·2026
Same author

AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for ependymomas.

Brain pathology (Zurich, Switzerland)·2026
Same author

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

MC1 detects tau pathology in chronic traumatic encephalopathy.

Journal of neuropathology and experimental neurology·2026
Same author

Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank.

Journal of neuro-oncology·2026
Same author

Spatial characterisation of TREM2 expression in actively demyelinating multiple sclerosis lesions supports its key roles in lipid metabolic pathways.

Acta neuropathologica communications·2026

Related Experiment Video

Updated: Aug 9, 2025

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

12.4K

Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics.

Ágota Tűzesi1,2, Susannah Hallal1,2,3, Laveniya Satgunaseelan1,4

  • 1Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.

Cancers
|February 25, 2023
PubMed
Summary

Epitranscriptomics, focusing on N6-methyladenine (m6A) RNA modifications, offers potential diagnostic and predictive tools for complex brain tumors. Understanding these RNA regulators in glioma biology could lead to new cancer classification strategies.

Keywords:
RNA regulationdiagnosticsepitranscriptomicsgliomam6A RNA methylation

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Related Experiment Videos

Last Updated: Aug 9, 2025

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

12.4K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • RNA modifications are dynamic transcript alterations with crucial roles in cellular pathways and disease.
  • Epitranscriptomics, the study of RNA modifications, is an emerging field focusing on N6-methyladenine (m6A), the most abundant mRNA modification.
  • m6A levels are regulated by specific protein families ('writers', 'readers', 'erasers') and are implicated in various cancers.

Purpose of the Study:

  • To review the current understanding of RNA modifications in glioma biology.
  • To explore the potential of epitranscriptomics for developing novel diagnostic and predictive tools for brain tumors.
  • To investigate how epitranscriptomic markers can stratify complex and heterogeneous glioma subtypes.

Main Methods:

  • Literature review of current research on RNA modifications and epitranscriptomics in cancer.
  • Analysis of the roles of m6A regulators (writers, readers, erasers) in glioma development and progression.
  • Examination of gene expression data related to RNA modification machinery in brain tumors.

Main Results:

  • The abundance and expression levels of genes encoding m6A regulators show promise as biomarkers.
  • Aberrant m6A modification patterns are increasingly recognized in the development and heterogeneity of gliomas.
  • Specific m6A profiles correlate with different glioma subtypes and patient outcomes.

Conclusions:

  • Epitranscriptomics, particularly the study of m6A, presents a promising avenue for advancing glioma diagnostics and prognostics.
  • Understanding the regulatory network of RNA modifications in glioma can facilitate the development of targeted therapies.
  • The potential for stratifying brain tumors using epitranscriptomic signatures highlights a new frontier in precision oncology.